Get the Stockscreener App
77.40
2.79%
2.10
Genedx Holdings Corp stock is traded at $77.40, with a volume of 670.08K.
It is up +2.79% in the last 24 hours and up +11.56% over the past month.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
See More
Previous Close:
$75.30
Open:
$72.35
24h Volume:
670.08K
Relative Volume:
1.08
Market Cap:
$2.13B
Revenue:
$267.23M
Net Income/Loss:
$-83.50M
P/E Ratio:
-2.1766
EPS:
-35.5597
Net Cash Flow:
$-59.99M
1W Performance:
+2.61%
1M Performance:
+11.56%
6M Performance:
+187.73%
1Y Performance:
+2,935%
1-Day Range:
$72.25
$78.75
1-Week Range:
$72.25
$83.78
52-Week Range:
$2.466
$89.11
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
617 780 8742
Address
333 LUDLOW STREET, STAMFORD
Compare WGS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
77.40 | 2.13B | 267.23M | -83.50M | -59.99M | -3.11 |
|
VEEV
Veeva Systems Inc
|
224.15 | 36.39B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
66.83 | 11.55B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
57.83 | 10.80B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
94.95 | 8.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.82 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
Genedx Holdings Corp Stock (WGS) Latest News
GeneDx (NASDAQ:WGS) Shares Gap DownShould You Sell? - MarketBeat
When the Price of (WGS) Talks, People Listen - Stock Traders Daily
Katherine Stueland Sells 10,501 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) Stock - MarketBeat
GeneDx Holdings Corp. (NASDAQ:WGS) CFO Kevin Feeley Sells 3,728 Shares - MarketBeat
Genedx CFO Kevin Feeley sells $286,139 in stock - Investing.com
GeneDx CEO Katherine Stueland sells $805,994 in stock By Investing.com - Investing.com UK
GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
Is GeneDx Holdings (NASDAQ:WGS) Using Too Much Debt? - Simply Wall St
GeneDx: Possibly Turning A Profit In 2025 (Rating Downgrade) - Seeking Alpha
Fmr LLC Increases Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Short Interest in GeneDx Holdings Corp. (NASDAQ:WGSWW) Increases By 20.0% - Defense World
GeneDx (NASDAQ:WGS) Shares Up 4.8%What's Next? - MarketBeat
GeneDx Holdings Corp. (NASDAQ:WGS) Shares Bought by Charles Schwab Investment Management Inc. - MarketBeat
The Genomics Giant on the Verge of Breakthrough. Will GeneDx Turn the Tide? - Jomfruland.net
GeneDx Holdings Corp. (NASDAQ:WGS): Is Breakeven Near? - Yahoo Finance
GeneDx Rides Revenue Surge, But Valuation Risks Loom (NASDAQ:WGS) - Seeking Alpha
7,297 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Purchased by MetLife Investment Management LLC - MarketBeat
Jacobs Levy Equity Management Inc. Has $2.88 Million Stock Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Point72 Asset Management L.P. Has $12.46 Million Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Analysts Set GeneDx Holdings Corp. (NASDAQ:WGS) Price Target at $59.33 - MarketBeat
GeneDx Holdings Corp (WGS) Shares Up 5.33% on Dec 4 - GuruFocus.com
177,500 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Healthcare of Ontario Pension Plan Trust Fund - MarketBeat
SEMA4 HOLDINGS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Sema4 Holdings Corp.SMFR - Marketscreener.com
Summit Partners Public Asset Management LLC Makes New $7.34 Million Investment in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Algert Global LLC Acquires 52,526 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Genedx CFO Kevin Feeley sells $1.65M in stock - Investing.com India
Insider Sell: Kevin Feeley Sells 22,000 Shares of GeneDx Holdings Corp (WGS) - GuruFocus.com
Genedx CFO Kevin Feeley sells $1.65M in stock By Investing.com - Investing.com Canada
Connor Clark & Lunn Investment Management Ltd. Purchases Shares of 60,005 GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Principal Financial Group Inc. Buys Shares of 14,240 GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx Holdings Corp (WGS) Stock Price Up 5.52% on Oct 11 - GuruFocus.com
GeneDx Holdings Corp.'s (NASDAQ:WGS) P/S Is Still On The Mark Following 40% Share Price Bounce - Simply Wall St
7,577 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Acquired by GSA Capital Partners LLP - MarketBeat
GeneDx to Participate in Upcoming Investor Conference - Business Wire
Genedx director Ryan sells shares worth $3.3 million By Investing.com - Investing.com Canada
Genedx director Ryan sells shares worth $3.3 million - Investing.com
GeneDx Holdings Corp. (WGS) Tops Q3 Earnings and Revenue Estimates - MSN
Thompson Davis & CO. Inc. Sells 7,244 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Insider Sell Alert: Katherine Stueland Sells 45,415 Shares of Ge - GuruFocus.com
Katherine Stueland Sells 22,307 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) Stock - MarketBeat
28,293 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Acquired by Royce & Associates LP - MarketBeat
GeneDx CEO Katherine Stueland sells $3.2m in stock - Investing.com
GeneDx CEO Katherine Stueland sells $3.2m in stock By Investing.com - Investing.com UK
GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover - Business Wire
Mount Sinai Health System sells $10.4 million in GeneDx shares - Investing.com
GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary - Business Wire
GeneDx Holdings Corp. (NASDAQ:WGSWW) Sees Significant Increase in Short Interest - Defense World
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year - The Motley Fool
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year - The Motley Fool
Chartwell Investment Partners LLC Purchases New Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx Holdings Corp (WGS) Shares Up 5.13% on Nov 12 - GuruFocus.com
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Genedx Holdings Corp Stock (WGS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Stueland Katherine | Chief Executive Officer |
Dec 16 '24 |
Sale |
76.75 |
10,501 |
805,995 |
71,146 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Dec 16 '24 |
Option Exercise |
0.00 |
7,197 |
0 |
31,928 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Dec 16 '24 |
Sale |
76.75 |
3,728 |
286,139 |
28,200 |
1.16%
0.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):